Effect of treatment with rhGM-CSF and low-dose cytosine arabinoside on leukemic blast cells in patients with myelodysplastic syndromes.

Hoelzer, D., Ganser, A., Ottmann, O. G., Höffken, K., Becher, R., Lutz, D., … Boogaerts, M. A. (1990). Effect of treatment with rhGM-CSF and low-dose cytosine arabinoside on leukemic blast cells in patients with myelodysplastic syndromes. Haematology and Blood Transfusion, 33, 763–769. https://doi.org/10.1007/978-3-642-74643-7_138